Total Payments
$93,512
2024 Payments
$125.34
Companies
14
Transactions
245
Medicare Patients
94
Medicare Billing
$8,757
Payment Breakdown by Category
Other$75,615 (80.9%)
Consulting$6,500 (7.0%)
Travel$6,392 (6.8%)
Food & Beverage$4,988 (5.3%)
Education$16.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $75,616 | 45 | 80.9% |
| Consulting Fee | $6,500 | 3 | 7.0% |
| Travel and Lodging | $6,392 | 42 | 6.8% |
| Food and Beverage | $4,988 | 152 | 5.3% |
| Education | $16.80 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $59,506 | 85 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $27,254 | 68 | $0 (2021) |
| ITI, Inc. | $5,134 | 9 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $783.16 | 35 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $371.53 | 22 | $0 (2020) |
| Alkermes, Inc. | $211.24 | 11 | $0 (2021) |
| Allergan, Inc. | $75.86 | 5 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $40.16 | 2 | $0 (2019) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $37.85 | 2 | $0 (2017) |
| Shire North American Group Inc | $29.15 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.34 | 1 | Janssen Pharmaceuticals, Inc ($125.34) |
| 2023 | $91.18 | 1 | Janssen Pharmaceuticals, Inc ($91.18) |
| 2022 | $19.11 | 1 | ITI, Inc. ($19.11) |
| 2021 | $25,580 | 35 | Teva Pharmaceuticals USA, Inc. ($23,065) |
| 2020 | $11,745 | 20 | Teva Pharmaceuticals USA, Inc. ($8,861) |
| 2019 | $9,910 | 49 | Teva Pharmaceuticals USA, Inc. ($9,287) |
| 2018 | $23,469 | 55 | Teva Pharmaceuticals USA, Inc. ($12,860) |
| 2017 | $22,573 | 83 | Otsuka America Pharmaceutical, Inc. ($16,592) |
All Payment Transactions
245 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $125.34 | General |
| Category: Neuroscience | ||||||
| 11/01/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $91.18 | General |
| Category: Neuroscience | ||||||
| 01/06/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: PSYCHIATRY | ||||||
| 12/14/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: Central Nervous System | ||||||
| 12/14/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: Central Nervous System | ||||||
| 11/04/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,570.00 | General |
| Category: Central Nervous System | ||||||
| 11/04/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Travel and Lodging | Cash or cash equivalent | $178.08 | General |
| Category: Central Nervous System | ||||||
| 11/04/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $105.70 | General |
| Category: Central Nervous System | ||||||
| 11/04/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | Cash or cash equivalent | $9.14 | General |
| Category: Central Nervous System | ||||||
| 10/21/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,570.00 | General |
| Category: Central Nervous System | ||||||
| 10/21/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Travel and Lodging | Cash or cash equivalent | $238.00 | General |
| Category: Central Nervous System | ||||||
| 10/21/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $96.78 | General |
| Category: Central Nervous System | ||||||
| 10/21/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | Cash or cash equivalent | $8.31 | General |
| Category: Central Nervous System | ||||||
| 10/07/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Neuroscience | ||||||
| 09/01/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Central Nervous System | ||||||
| 08/26/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,570.00 | General |
| Category: Central Nervous System | ||||||
| 08/26/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Travel and Lodging | Cash or cash equivalent | $288.96 | General |
| Category: Central Nervous System | ||||||
| 08/26/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Travel and Lodging | Cash or cash equivalent | $186.26 | General |
| Category: Central Nervous System | ||||||
| 08/26/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $121.49 | General |
| Category: Central Nervous System | ||||||
| 08/26/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | Cash or cash equivalent | $35.82 | General |
| Category: Central Nervous System | ||||||
| 08/25/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: Central Nervous System | ||||||
| 08/25/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $93.66 | General |
| Category: Central Nervous System | ||||||
| 08/25/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Travel and Lodging | Cash or cash equivalent | $30.24 | General |
| Category: Central Nervous System | ||||||
| 08/19/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Neuroscience | ||||||
| 07/01/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 49 | 80 | $13,021 | $4,061 |
| 2020 | 3 | 45 | 89 | $11,850 | $4,696 |
Total Patients
94
Total Services
169
Medicare Billing
$8,757
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 21 | 34 | $5,498 | $1,760 | 32.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 12 | 17 | $3,976 | $1,231 | 30.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 29 | $3,547 | $1,071 | 30.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 21 | 51 | $6,375 | $2,840 | 44.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 11 | 21 | $4,200 | $1,513 | 36.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 13 | 17 | $1,275 | $343.66 | 27.0% |
About Dr. Eric Fan, D.O
Dr. Eric Fan, D.O is a Psychiatry healthcare provider based in Albany, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1629191663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Fan, D.O has received a total of $93,512 in payments from pharmaceutical and medical device companies, with $125.34 received in 2024. These payments were reported across 245 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($75,616).
As a Medicare-enrolled provider, Fan has provided services to 94 Medicare beneficiaries, totaling 169 services with total Medicare billing of $8,757. Data is available for 2 years (2020–2021), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Albany, GA
- Active Since 04/06/2007
- Last Updated 08/19/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1629191663
Products in Payments
- AUSTEDO (Drug) $58,922
- REXULTI (Drug) $17,336
- ABILIFY MAINTENA (Drug) $9,918
- CAPLYTA (Drug) $5,134
- INVEGA SUSTENNA (Drug) $599.68
- SD809-TD (Drug) $584.82
- LATUDA (Drug) $371.53
- INVEGA TRINZA (Drug) $169.04
- Aristada 441 mg (Drug) $97.89
- ARISTADA (Drug) $97.09
- VRAYLAR (Drug) $75.86
- NUEDEXTA (Drug) $40.16
- VYVANSE (Drug) $29.15
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $22.78
- Victoza (Drug) $19.11
- Vivitrol 380 mg (Drug) $16.26
- Fanapt (Drug) $14.95
- SPRAVATO (Drug) $14.44
- Adzenys XR-ODT (Drug) $12.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Albany
Dr. Sasi Nayudu, Md, MD
Psychiatry — Payments: $181,134
Psychiatry $181,134
Dr. David Pallas, M.d, M.D
Psychiatry — Payments: $19,246
Psychiatry $19,246
Dr. Steven Kronick, M.d, M.D
Psychiatry — Payments: $15,695
Psychiatry $15,695
Dr. Joshua Heller, Md, MD
Psychiatry — Payments: $10,408
Psychiatry $10,408
Dr. Joseph Calleja, M.d, M.D
Psychiatry — Payments: $2,979
Psychiatry $2,979
Dr. Robin Tassinari, M.d, M.D
Psychiatry — Payments: $1,585
Psychiatry $1,585